Immunohistochemical parameters in patients with NSCLC
| Number | % | |
|---|---|---|
| NSCLC, non-small cell lung cancer; VEGF, vascular endothelial growth factor. | ||
| CD34 | ||
| Low | 21/51 | 41.2% |
| High | 30/51 | 58.8% |
| CD105 | ||
| Low | 17/51 | 33.3% |
| High | 34/51 | 66.7% |
| CD31 | ||
| Low | 20/51 | 39.2% |
| High | 31/51 | 60.8% |
| VEGF | ||
| Low | 9/51 | 17.6% |
| High | 42/51 | 82.4% |
| Tumour vessel invasion | ||
| No | 38/51 | 74.5% |
| Yes | 13/51 | 25.5% |